As TCS prepares to release its Q2FY26 earnings, analysts predict a slowdown in revenue and profit growth, primarily influenced by the BFSI sector's resilience and ongoing challenges in consumer and pharma verticals. Key focus areas include H1B visa impacts and upcoming deal pipelines.